EUVIMEDEUVIMED entdecken
Crossref

Safety of a Pulmonary Embolism Ambulatory Treatment Program

Mahir M. Hamad, Elrasheed A. Ellidir, Charlotte Routh, Siraj O. Wali, Vincent M. Connolly

Saudi Journal of Internal Medicine · 2011

DOI: 10.32790/sjim.1.1.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Journal of Internal Medicine, 2011. Verfasst von Mahir M. Hamad und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Evidence has emerged that out-patient management of pulmonary embolism may be an appropriate option in selected patients. This report is based on a safety data on a Pulmonary Embolism Ambulatory Treatment program.

Methods

An observational study in acute assessment unit from 2000-2006, of all consecutive patients with confirmed pulmonary embolism (high probability ventilation-perfusion scan or computerized tomography pulmonary angiography), have been evaluated. Exclusion criteria were oxygen saturation less than 92%; systolic blood pressure less than 100 mm Hg; significant cardiopulmonary or renal disease, and a bleeding risk. Patient treated initially with low molecular weight heparin followed by oral anticoagulants when diagnosis was confirmed and were assessed at 3 and 6 months.

Results

Sixty-one patients (33 females), median age 55 (range; 16-89 years) were eligible. Patients needed a maximum of 13 appointments. Risk factors included surgery (8.2%), cancer (8.2%), long travel (14.8%), previous thromboembolism (14.8%), hormonal replacement therapy (3.3%) and contraceptive pill (8.2%). No risk factor was identified at 37.7%. The mortality was zero at 6 months. No complications were recorded. Four patients required hospital admission, all within the first week; all were discharged within 24 hours. The median length of stay for patients with uncomplicated pulmonary embolism was 7 days; implementation of the pulmonary embolism ambulatory treatment program saved 427 bed days.

Conclusion

The pulmonary embolism ambulatory treatment program was cost-effective and was not associated with serious complications. Further evaluation of these programs could help establish the safety and cost-effectiveness of this approach.

Zitieren

APA

Hamad, M. M., Ellidir, E. A., Routh, C., Wali, S. O., & Connolly, V. M. (2011). Safety of a Pulmonary Embolism Ambulatory Treatment Program. Saudi Journal of Internal Medicine. https://doi.org/10.32790/sjim.1.1.4

Vancouver

Hamad MM, Ellidir EA, Routh C, Wali SO, Connolly VM. Safety of a Pulmonary Embolism Ambulatory Treatment Program. Saudi Journal of Internal Medicine. 2011. doi:10.32790/sjim.1.1.4

BibTeX
@article{Hamad2011,
  author = {Hamad, Mahir M. and Ellidir, Elrasheed A. and Routh, Charlotte and Wali, Siraj O. and Connolly, Vincent M.},
  title = {Safety of a Pulmonary Embolism Ambulatory Treatment Program},
  journal = {Saudi Journal of Internal Medicine},
  year = {2011},
  doi = {10.32790/sjim.1.1.4}
}
Kostenlos starten →